Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1.7 [1.32-2.18],3.56595284025467e-05,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.22 [1.08-1.37],0.00088041464572557,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.73 [0.6-0.88],0.00137399376422663,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.64 [0.48-0.86],0.00288864533276645,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,OGN,Mimecan,Inverse variance weighted,30,1.44 [1.1-1.88],0.00740615089230629,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.55 [0.35-0.86],0.00963750642262659,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.74 [0.59-0.93],0.0110699857938583,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.39 [1.04-1.86],0.0247703110003018,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.38 [1.03-1.83],0.028883555469194,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,1.98 [1.07-3.68],0.0302253098251336,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,1.22 [1.01-1.46],0.0355339758494656,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.6 [1.01-2.55],0.04473250867736,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.31 [1-1.72],0.0470700772791131,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LGALS4,Galectin-4,Inverse variance weighted,4,0.55 [0.3-1.01],0.0534904353770541,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.51 [0.26-1.03],0.0593057772569328,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.57 [0.98-2.5],0.0617179973700935,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,2.02 [0.95-4.29],0.0666368950173602,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.39 [0.97-1.98],0.0715325307695532,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.54 [0.27-1.06],0.0735230590097373,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCN3,CCN family member 3,Inverse variance weighted,19,1.3 [0.97-1.75],0.0794618689468436,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,15,1.22 [0.98-1.54],0.0795025277011295,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.68 [0.44-1.05],0.0818480478787205,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.25 [0.97-1.61],0.0862046189829784,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.83 [0.67-1.03],0.096891296218266,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.14 [0.98-1.33],0.0989655863730604,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,2.17 [0.85-5.55],0.104344422834555,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.58 [0.3-1.15],0.117987815725254,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,1.18 [0.95-1.46],0.130138180426461,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.48 [0.18-1.3],0.147996916407014,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,0.74 [0.49-1.12],0.15219200355151,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,0.87 [0.71-1.06],0.156641288719595,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,7.99 [0.41-156.65],0.171226321994169,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.66 [0.35-1.22],0.180235925612025,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.12 [0.95-1.31],0.183549962337691,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.83 [0.63-1.1],0.189603323122005,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REN,Renin,Inverse variance weighted,4,1.26 [0.89-1.79],0.192451448267473,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.62 [0.3-1.28],0.193945685021124,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.61 [0.28-1.29],0.194138051765377,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,8,0.73 [0.45-1.18],0.195735960767744,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.23 [0.02-2.23],0.202831906037149,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD46,Membrane cofactor protein,Wald ratio,1,2.06 [0.68-6.25],0.203307218248101,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.87 [0.69-1.08],0.209097722598366,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,VWC2,Brorin,Inverse variance weighted,22,0.85 [0.65-1.1],0.213088037894579,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.83 [0.63-1.11],0.213105736771288,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD276,CD276 antigen,Inverse variance weighted,20,0.9 [0.77-1.06],0.222948264928775,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.51 [0.17-1.5],0.223033483917952,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PSAP,Prosaposin,Inverse variance weighted,5,1.45 [0.8-2.64],0.22494045425968,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.22 [0.89-1.67],0.225913886546798,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CHGA,Chromogranin-A,Inverse variance weighted,3,1.36 [0.83-2.24],0.228506986982218,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,COLEC12,Collectin-12,Inverse variance weighted,11,0.79 [0.55-1.16],0.228596914658837,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.51 [0.17-1.53],0.230505216331091,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.49 [0.15-1.59],0.233392771803678,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.63 [0.71-3.73],0.244628994898913,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.85 [0.64-1.12],0.25463259937427,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,0.54 [0.18-1.63],0.276771970707063,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,BSG,Basigin,Wald ratio,1,0.67 [0.33-1.38],0.277919249865608,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,3.62 [0.35-37.32],0.280092356986483,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.2 [0.86-1.66],0.286782786525953,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,6,1.5 [0.71-3.17],0.288872303860523,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,11,0.8 [0.52-1.21],0.288949819145854,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.22 [0.84-1.77],0.288951498400923,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.91 [0.75-1.09],0.29148014159898,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,0.8 [0.53-1.22],0.300841598612904,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,KLK11,Kallikrein-11,Inverse variance weighted,6,0.9 [0.73-1.1],0.301290999314317,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.78 [0.49-1.25],0.302964284591742,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.75 [0.43-1.3],0.30300555295104,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,0.84 [0.6-1.18],0.310489392452595,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.83 [0.58-1.19],0.314628941358763,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.09 [0.92-1.3],0.315123341511488,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD27,CD27 antigen,Inverse variance weighted,9,0.86 [0.65-1.15],0.319686863513547,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CDH1,Cadherin-1,Wald ratio,1,0.34 [0.04-2.85],0.319839179889911,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.63 [0.61-4.34],0.329576758737822,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CTSD,Cathepsin D,Inverse variance weighted,17,0.87 [0.66-1.15],0.329840171678213,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,2.38 [0.41-13.65],0.331951614300007,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.89 [0.7-1.13],0.332130459794167,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.85 [0.62-1.18],0.336568050451465,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.28 [0.02-3.74],0.337028881375673,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,0.81 [0.53-1.24],0.339703089386263,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RSPO3,R-spondin-3,Inverse variance weighted,6,1.28 [0.77-2.14],0.342057023922347,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.52 [0.63-3.65],0.348855658364917,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,1.2 [0.81-1.78],0.35553175559725,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,1.07 [0.92-1.24],0.39513112916883,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.44 [0.61-3.38],0.400988983497059,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.77 [0.41-1.43],0.404583690751039,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.86 [0.6-1.24],0.409581551344168,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LGALS9,Galectin-9,Inverse variance weighted,26,0.91 [0.74-1.13],0.412798528852816,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.1 [0.87-1.38],0.423677744053554,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.9 [0.69-1.17],0.429911866656868,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPON1,Spondin-1,Inverse variance weighted,21,0.9 [0.69-1.17],0.430176287739176,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,0.94 [0.8-1.1],0.4356055958652,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.84 [0.39-8.64],0.437719308351144,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MDK,Midkine,Inverse variance weighted,4,1.43 [0.58-3.54],0.442162551868523,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PALM2,Paralemmin-2,Inverse variance weighted,8,1.17 [0.78-1.75],0.44490178160124,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,KLK4,Kallikrein-4,Inverse variance weighted,17,0.92 [0.74-1.14],0.44680978095825,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,0.71 [0.3-1.71],0.450039901662729,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.2 [0.75-1.93],0.450752788606057,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NECTIN4,Nectin-4,Inverse variance weighted,7,0.87 [0.62-1.24],0.45278177533272,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFF3,Trefoil factor 3,Inverse variance weighted,5,1.23 [0.71-2.15],0.457184612217238,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CTSZ,Cathepsin Z,Inverse variance weighted,3,1.13 [0.81-1.58],0.4577116383335,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.43 [0.54-3.76],0.472970329157044,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AGRN,Agrin,Inverse variance weighted,17,0.88 [0.63-1.24],0.475448870106609,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.11 [0.84-1.46],0.475515554370803,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.65 [0.2-2.11],0.476985622489631,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.31 [0.62-2.75],0.478312463236052,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,OSM,Oncostatin-M,Wald ratio,1,1.67 [0.4-6.88],0.480567407371168,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SHISA5,Protein shisa-5,Inverse variance weighted,5,0.71 [0.27-1.88],0.488289728406371,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.46 [0.49-4.38],0.496854235755879,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD83,CD83 antigen,Inverse variance weighted,5,1.18 [0.72-1.94],0.513965390801558,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.14 [0.77-1.67],0.51496671153772,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,0.88 [0.61-1.29],0.522158569857799,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.83 [0.46-1.49],0.522630700714079,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.78 [0.37-1.66],0.525298548706699,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,0.92 [0.71-1.19],0.529103521003898,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RETN,Resistin,Inverse variance weighted,9,0.9 [0.65-1.25],0.529505990218031,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.3 [0.57-2.99],0.533450261181123,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,15,1.07 [0.86-1.34],0.534360554772712,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.67 [0.18-2.41],0.535120549661375,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,1.09 [0.83-1.44],0.538422209237655,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.88 [0.6-1.31],0.540306139356189,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCG2,Secretogranin-2,Wald ratio,1,0.52 [0.06-4.22],0.542509469364753,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,0.94 [0.78-1.14],0.552310842343853,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL15,Interleukin-15,Wald ratio,1,0.07 [0-517.06],0.552749097201687,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,0.92 [0.7-1.22],0.556989360510462,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,0.82 [0.42-1.61],0.567745941786564,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AGRP,Agouti-related protein,Inverse variance weighted,3,0.61 [0.11-3.4],0.570573365078011,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,0.89 [0.57-1.37],0.585280474628932,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,1.05 [0.87-1.27],0.588596490611835,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.7 [0.19-2.58],0.591974075639899,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.07 [0.82-1.4],0.600329024924838,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.96 [0.81-1.13],0.609330297987468,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.9 [0.59-1.36],0.609522987598509,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.95 [0.8-1.14],0.609856511768732,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,UMOD,Uromodulin,Inverse variance weighted,29,0.97 [0.85-1.1],0.610231927023567,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.93 [0.7-1.24],0.624990699659171,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.92 [0.66-1.28],0.633187531976174,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.96 [0.81-1.14],0.637160808460258,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,1.03 [0.92-1.14],0.643925973303847,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.15 [0.64-2.06],0.644040155439467,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,0.86 [0.45-1.64],0.649012765472342,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD302,CD302 antigen,Inverse variance weighted,9,0.93 [0.66-1.29],0.649304882027806,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,0.96 [0.82-1.13],0.649938153084972,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SEPTIN8,Septin-8,Inverse variance weighted,2,0.85 [0.43-1.71],0.657353848513146,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PRSS8,Prostasin,Inverse variance weighted,5,0.82 [0.33-2.02],0.670719024695946,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.69 [0.13-3.77],0.671061886907388,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.58 [0.05-6.99],0.67163139066584,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.88 [0.49-1.6],0.68320024463913,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.07 [0.77-1.47],0.70296612788008,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.78 [0.22-2.79],0.705129747677129,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LMNB2,Lamin-B2,Wald ratio,1,1.59 [0.14-18],0.707087403226266,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.93 [0.63-1.38],0.711979191010433,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.97 [0.85-1.12],0.714575145345547,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.89 [0.47-1.68],0.715051457351808,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.89 [0.47-1.69],0.718025262878322,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.04 [0.82-1.32],0.718811883434715,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.96 [0.76-1.21],0.732725352021381,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.12 [0.58-2.19],0.732853040645456,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AMBP,Protein AMBP,Inverse variance weighted,3,1.12 [0.58-2.16],0.733934111263864,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.07 [0.72-1.6],0.736150745492639,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.98 [0.87-1.11],0.741748844560006,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.04 [0.82-1.32],0.742634070595351,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AREG,Amphiregulin,Inverse variance weighted,3,0.9 [0.47-1.71],0.747424142525702,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.16 [0.46-2.95],0.74790497089877,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NECTIN2,Nectin-2,Inverse variance weighted,5,1.05 [0.76-1.46],0.757432457196518,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.04 [0.79-1.38],0.758653213011697,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.79 [0.17-3.6],0.758751026086623,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.91 [0.48-1.72],0.762910560911218,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DSC2,Desmocollin-2,Inverse variance weighted,9,0.94 [0.65-1.38],0.764886487073076,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.04 [0.8-1.35],0.779074853233621,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.88 [0.35-2.22],0.779257935503454,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.93 [0.54-1.58],0.78207072056385,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CST3,Cystatin-C,Inverse variance weighted,10,0.96 [0.71-1.29],0.788028208638713,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,0.93 [0.55-1.58],0.788612752365522,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.95 [0.66-1.37],0.792437699131865,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CSTB,Cystatin-B,Inverse variance weighted,28,0.98 [0.81-1.18],0.808697096007784,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.06 [0.68-1.64],0.810143321365606,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.03 [0.8-1.33],0.811383120384814,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.95 [0.6-1.51],0.817747385405801,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.05 [0.7-1.56],0.822553554791227,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.04 [0.71-1.54],0.827852603595561,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.03 [0.77-1.38],0.831880615133113,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.83 [0.14-5.03],0.835045234104176,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.05 [0.68-1.61],0.838453883238482,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,6,0.95 [0.58-1.56],0.838463212420486,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.04 [0.69-1.56],0.845589008610016,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EFNA4,Ephrin-A4,Inverse variance weighted,3,1.1 [0.42-2.85],0.846841695051912,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.94 [0.5-1.79],0.854660171738157,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,0.98 [0.84-1.16],0.855689748408485,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.86 [0.17-4.39],0.856365333825777,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,0.98 [0.76-1.26],0.865096769344447,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,0.96 [0.62-1.5],0.865791389191415,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MMP7,Matrilysin,Inverse variance weighted,13,1.02 [0.78-1.34],0.870332112885349,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PRSS2,Trypsin-2,Inverse variance weighted,3,1.09 [0.37-3.17],0.873802625640957,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,OCLN,Occludin,Inverse variance weighted,2,1.1 [0.34-3.54],0.874570140895165,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.98 [0.73-1.3],0.876748363015158,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,0.95 [0.5-1.81],0.876784234168779,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.04 [0.63-1.71],0.878098116403437,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,0.99 [0.84-1.16],0.886591856976786,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.98 [0.77-1.25],0.889446626811326,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPON2,Spondin-2,Inverse variance weighted,4,0.97 [0.64-1.49],0.901596274525555,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.97 [0.56-1.66],0.902559237242654,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PENK,Proenkephalin-A,Inverse variance weighted,19,1.02 [0.79-1.31],0.907054502542648,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.91 [0.19-4.42],0.910186281805732,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.01 [0.79-1.31],0.911009975670118,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LAYN,Layilin,Inverse variance weighted,20,1.02 [0.76-1.36],0.917340089601302,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.98 [0.61-1.56],0.91788418369923,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.06 [0.33-3.46],0.919370566246014,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.06 [0.3-3.72],0.926128630290256,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.03 [0.54-1.95],0.927434980427982,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RBP2,Retinol-binding protein 2,Wald ratio,1,1.07 [0.21-5.46],0.933561334470227,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1.08 [0.16-7.4],0.935728037941507,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.94 [0.2-4.32],0.936405331036832,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,1.04 [0.36-3.07],0.936571673023233,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.97 [0.43-2.24],0.952041531869452,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,0.99 [0.74-1.33],0.960928305426699,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CDH3,Cadherin-3,Inverse variance weighted,2,1.03 [0.29-3.66],0.960938271773435,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EDN1,Endothelin-1,Inverse variance weighted,3,1.01 [0.65-1.57],0.964749649762778,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,2,1.03 [0.24-4.35],0.968982510912942,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,1 [0.79-1.28],0.970752961957568,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1 [0.86-1.16],0.978946483696198,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PGF,Placenta growth factor,Inverse variance weighted,2,0.96 [0.03-34.02],0.982890030521852,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,10,1 [0.75-1.32],0.984370811464384,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,1 [0.74-1.35],0.991246736731432,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1 [0.62-1.61],0.993478314745811,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DPY30,Protein dpy-30 homolog,Wald ratio,1,1 [0.1-9.9],0.99915474724567,cis
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.23 [1.09-1.38],0.000524748838965299,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,8,0.43 [0.25-0.73],0.00186396272107936,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,OGN,Mimecan,Inverse variance weighted,37,1.44 [1.13-1.84],0.00281584773281376,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.17 [0.05-0.54],0.00298234205710916,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.76 [0.63-0.92],0.00437426119241245,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,3,6.1 [1.74-21.4],0.00472967830844823,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.51 [0.31-0.84],0.00745785701086896,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.65 [0.47-0.9],0.00879815273162631,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,WNT9A,Protein Wnt-9a,Wald ratio,1,39.98 [2.42-661.16],0.00997384859882515,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.26 [1.03-1.54],0.0242311154980882,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.63 [0.42-0.95],0.0264599372378523,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LGALS4,Galectin-4,Inverse variance weighted,15,0.75 [0.59-0.97],0.0270226585048879,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.34 [0.13-0.93],0.0357054987676156,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD83,CD83 antigen,Inverse variance weighted,14,0.59 [0.35-0.97],0.0366037547853184,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.66 [1.02-2.68],0.0402781374090204,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.4 [1-1.95],0.0467163527512606,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.75 [0.56-1.01],0.0543899658671307,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GP1BA,Platelet glycoprotein Ib alpha chain,Inverse variance weighted,24,1.45 [0.97-2.16],0.0668520821212883,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,2.1 [0.95-4.67],0.0679123536669704,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.78 [0.59-1.02],0.0699941939527326,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,1.17 [0.99-1.38],0.0715155529881068,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,2.31 [0.91-5.87],0.0793494027533307,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,1.43 [0.95-2.16],0.089519168240873,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.74 [0.91-3.33],0.0927418310079466,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.56 [0.28-1.11],0.0963570116734025,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.33 [0.95-1.86],0.096756318342851,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.19 [0.03-1.36],0.0970912003786247,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,29,1.19 [0.97-1.46],0.102501649742466,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.4 [0.12-1.28],0.120844765945778,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PSAP,Prosaposin,Inverse variance weighted,13,1.29 [0.94-1.78],0.121106423807923,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.83 [0.84-3.96],0.127334632565204,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SHISA5,Protein shisa-5,Inverse variance weighted,12,0.57 [0.28-1.18],0.128587038990195,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,1.47 [0.9-2.4],0.128711176192748,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,0.67 [0.4-1.13],0.132064243788598,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,1.71 [0.85-3.43],0.133494753000778,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.48 [0.18-1.26],0.134400101335579,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD27,CD27 antigen,Inverse variance weighted,9,2.16 [0.79-5.92],0.134432283785303,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CTSD,Cathepsin D,Inverse variance weighted,7,1.93 [0.8-4.66],0.141642349827464,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,0.6 [0.3-1.2],0.149173707575572,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CHGA,Chromogranin-A,Inverse variance weighted,5,0.59 [0.28-1.21],0.150386288818154,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MMP7,Matrilysin,Wald ratio,1,0.52 [0.21-1.28],0.15355760229285,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,STC2,Stanniocalcin-2,Inverse variance weighted,10,1.58 [0.83-3],0.159299172481631,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,0.87 [0.72-1.06],0.160015572673998,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,12,0.68 [0.39-1.17],0.166153945521242,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD276,CD276 antigen,Inverse variance weighted,24,0.8 [0.58-1.11],0.175545880778007,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.71 [0.43-1.17],0.178196627116465,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,BSG,Basigin,Inverse variance weighted,6,1.8 [0.76-4.26],0.178231808152982,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CDH3,Cadherin-3,Inverse variance weighted,10,1.48 [0.83-2.64],0.17991361919493,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.46 [0.83-2.59],0.190184295934018,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,0.6 [0.27-1.3],0.192833712717366,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.51 [0.18-1.43],0.200272019406299,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.55 [0.79-3.07],0.203528831167354,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCG2,Secretogranin-2,Inverse variance weighted,2,0.45 [0.13-1.55],0.206153584503637,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,UMOD,Uromodulin,Inverse variance weighted,34,1.23 [0.89-1.71],0.209805139979123,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.64 [0.31-1.29],0.211309361735874,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.48 [0.8-2.74],0.212561045101831,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.8 [0.57-1.14],0.21634220131371,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,2.13 [0.63-7.17],0.22185949865781,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,4.46 [0.4-49.54],0.223371729415813,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GAST,Gastrin,Inverse variance weighted,9,0.65 [0.31-1.33],0.238803252108786,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FAM3C,Protein FAM3C,Inverse variance weighted,3,0.53 [0.18-1.53],0.239113358884707,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.72 [0.42-1.24],0.241552620055536,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EFNA1,Ephrin-A1,Inverse variance weighted,3,0.55 [0.2-1.52],0.251361089250098,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,0.58 [0.23-1.49],0.256957247645023,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,0.53 [0.17-1.65],0.270773214119278,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,2.04 [0.57-7.32],0.272551016683533,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.45 [0.11-1.9],0.27596620311976,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.43 [0.09-2.01],0.280305889834607,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCN3,CCN family member 3,Inverse variance weighted,17,1.17 [0.87-1.58],0.285375143935696,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.62 [0.25-1.51],0.289050313152703,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PRSS8,Prostasin,Inverse variance weighted,14,0.78 [0.49-1.24],0.290294044082829,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.52 [0.15-1.78],0.295691412928173,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL6,Interleukin-6,Inverse variance weighted,6,0.77 [0.46-1.26],0.297102329850131,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,0.74 [0.41-1.31],0.300369031907244,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AGRN,Agrin,Inverse variance weighted,14,0.77 [0.46-1.28],0.310801929451573,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.54 [0.66-3.55],0.316596757626346,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.26 [0.79-2],0.329178899009425,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.45 [0.67-3.11],0.341828393325235,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PALM2,Paralemmin-2,Inverse variance weighted,9,1.24 [0.79-1.94],0.344594636219751,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,0.63 [0.24-1.65],0.34561060534278,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AMBP,Protein AMBP,Inverse variance weighted,5,1.33 [0.73-2.41],0.346995154800941,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.63 [0.24-1.65],0.349568367082797,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.86 [0.5-6.91],0.350851404486292,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.86 [0.5-6.92],0.356269245713921,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AGRP,Agouti-related protein,Inverse variance weighted,16,1.2 [0.82-1.75],0.357734464354733,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,0.74 [0.38-1.42],0.361728528495375,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.33 [0.72-2.44],0.362689569656817,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.69 [0.3-1.56],0.369390824762333,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.75 [0.4-1.41],0.373023373086767,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.68 [0.5-5.66],0.401019049332314,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.79 [0.45-1.38],0.401532659404581,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.41 [0.63-3.12],0.402355178400945,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.36 [0.63-2.96],0.431108183451231,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,XG,Glycoprotein Xg,Inverse variance weighted,2,1.93 [0.37-10.14],0.435865068312312,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,0.87 [0.61-1.24],0.439680283186924,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.55 [0.11-2.64],0.453888774366716,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.44 [0.55-3.77],0.458694537551983,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.54 [0.48-4.9],0.463721255640077,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RSPO3,R-spondin-3,Inverse variance weighted,5,1.37 [0.59-3.21],0.463963461168121,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.9 [0.33-11],0.473033090185847,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,INHBB,Inhibin beta B chain,Inverse variance weighted,11,0.76 [0.36-1.61],0.473352818956178,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.12 [0.82-1.53],0.475229419269335,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.56 [0.11-2.8],0.47789649760851,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.57 [0.45-5.48],0.480847703723234,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.89 [0.64-1.24],0.482454659158142,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,0.84 [0.51-1.39],0.495417911908388,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.69 [0.37-7.73],0.497741839712202,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.51 [0.46-4.98],0.500762754853271,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.24 [0.66-2.33],0.507634294339447,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.28 [0.58-2.81],0.535058930330617,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.28 [0.57-2.87],0.541828538337258,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.59 [0.11-3.22],0.54333188378736,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.11 [0.8-1.53],0.545144366883786,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.46 [0.43-5.01],0.545174276284428,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.24 [0.62-2.46],0.54868884082998,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,2.32 [0.15-37.19],0.55147709755929,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,2.3 [0.15-36.38],0.553966384303042,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD99,CD99 antigen,Inverse variance weighted,4,0.78 [0.35-1.76],0.555459464358316,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.08 [0.83-1.42],0.558284618022266,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LMNB2,Lamin-B2,Inverse variance weighted,8,0.81 [0.39-1.68],0.563318293035792,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.07 [0.85-1.34],0.564692715522418,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.91 [0.65-1.26],0.568801081604119,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.94 [0.77-1.16],0.571386464637845,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.84 [0.44-1.58],0.584247210354168,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CDH1,Cadherin-1,Inverse variance weighted,16,1.08 [0.8-1.47],0.60171032376825,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,0.75 [0.25-2.25],0.602662031992081,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.06 [0.85-1.33],0.602745058257617,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DLL1,Delta-like protein 1,Inverse variance weighted,6,0.79 [0.32-1.94],0.603716166570588,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.42 [0.37-5.41],0.604474552802714,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,1.46 [0.35-6.13],0.604671848281841,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.22 [0.57-2.59],0.60584373317874,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.23 [0.56-2.71],0.606452789613002,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.23 [0.56-2.68],0.610455052816929,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.85 [0.46-1.57],0.61257842228209,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.55 [0.06-5.45],0.613421547773293,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.54 [0.05-6.07],0.61411763788545,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,OCLN,Occludin,Inverse variance weighted,2,1.72 [0.21-13.98],0.614243198948283,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.95 [0.76-1.17],0.621791259039512,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.16 [0.63-2.14],0.62428519089075,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.92 [0.64-1.3],0.625138049799422,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.11 [0.72-1.71],0.629132229466773,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DSC2,Desmocollin-2,Inverse variance weighted,16,1.08 [0.79-1.47],0.641893106329256,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.2 [0.55-2.61],0.648294121243405,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.05 [0.84-1.31],0.654619840032113,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,0.76 [0.21-2.76],0.673453096313937,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.2 [0.51-2.8],0.676292760276639,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.96 [0.78-1.18],0.680677651717568,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,0.55 [0.03-10.67],0.693224683148248,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PRSS2,Trypsin-2,Inverse variance weighted,17,0.93 [0.63-1.36],0.69814202056798,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,OSM,Oncostatin-M,Inverse variance weighted,6,1.15 [0.56-2.35],0.698527740746313,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.84 [0.33-2.14],0.716280021592724,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,1.08 [0.71-1.65],0.716536756077102,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NECTIN2,Nectin-2,Inverse variance weighted,3,1.34 [0.27-6.62],0.719839858165513,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,0.91 [0.55-1.5],0.719909062303616,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PGF,Placenta growth factor,Inverse variance weighted,5,1.17 [0.49-2.75],0.724296802261326,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.19 [0.44-3.26],0.72880856962736,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.39 [0.21-9.12],0.72978660981708,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CST3,Cystatin-C,Inverse variance weighted,3,0.79 [0.21-3.01],0.729950444800929,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.21 [0.4-3.62],0.732074402008166,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.08 [0.7-1.67],0.732866169831797,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,0.8 [0.22-2.9],0.739773319053814,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.13 [0.55-2.3],0.741318924540273,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.81 [0.23-2.81],0.742023845976481,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,0.9 [0.5-1.65],0.74294987805352,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFF3,Trefoil factor 3,Inverse variance weighted,10,0.89 [0.44-1.8],0.74853947873994,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,VWC2,Brorin,Inverse variance weighted,12,1.14 [0.52-2.47],0.748592753331666,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.14 [0.49-2.69],0.756283653503262,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD302,CD302 antigen,Inverse variance weighted,11,1.08 [0.64-1.82],0.761133733746831,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,14,1.07 [0.67-1.71],0.774706841962462,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,KLK11,Kallikrein-11,Inverse variance weighted,13,0.93 [0.57-1.53],0.775400692387563,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.91 [0.49-1.71],0.777731064835651,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.98 [0.82-1.16],0.779577672519054,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.75 [0.1-5.56],0.780115046163055,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.12 [0.49-2.55],0.78686347373425,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,0.83 [0.21-3.33],0.790403115904029,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,AREG,Amphiregulin,Inverse variance weighted,5,0.85 [0.24-2.95],0.794760851131534,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SEPTIN8,Septin-8,Inverse variance weighted,4,1.13 [0.46-2.78],0.795938203501952,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.23 [0.25-6.12],0.797801291613611,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,0.91 [0.44-1.88],0.798205712490563,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,17,1.06 [0.66-1.7],0.799010466162671,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.77 [0.1-6.16],0.802040539458648,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.94 [0.55-1.6],0.806555158217209,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.08 [0.6-1.95],0.807261238909884,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.81 [0.15-4.42],0.808395675737536,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NECTIN4,Nectin-4,Inverse variance weighted,4,1.19 [0.29-4.9],0.808670691777488,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.08 [0.58-2.01],0.813335558716593,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.9 [0.35-2.28],0.819767351354293,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,0.95 [0.62-1.46],0.820571951633076,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.95 [0.58-1.55],0.828672599598398,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RTN4R,Reticulon-4 receptor,Inverse variance weighted,8,1.08 [0.53-2.18],0.83340643361493,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.25 [0.16-10],0.836255324438957,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.15 [0.3-4.37],0.838814692202039,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.81 [0.11-6.28],0.843082427073906,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,0.77 [0.06-10.57],0.844804963244115,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,11,1.03 [0.79-1.34],0.846690807868665,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,1.09 [0.47-2.52],0.846927737475433,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.89 [0.29-2.8],0.848177776396982,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LAYN,Layilin,Inverse variance weighted,3,0.88 [0.23-3.41],0.850015646388141,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,1.26 [0.11-14.13],0.850367489224239,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,0.89 [0.26-3.06],0.856230526722914,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.86 [0.17-4.39],0.856365333825777,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPON1,Spondin-1,Inverse variance weighted,4,0.87 [0.19-3.97],0.859950194820071,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,REN,Renin,Inverse variance weighted,8,0.94 [0.46-1.92],0.865579200524,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.92 [0.34-2.46],0.868378262058275,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.04 [0.64-1.69],0.869046041240777,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD46,Membrane cofactor protein,Inverse variance weighted,2,0.89 [0.21-3.67],0.869341066116352,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,MDK,Midkine,Inverse variance weighted,14,1.05 [0.58-1.9],0.882610013533851,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,1.1 [0.3-4.02],0.882925939896646,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,0.93 [0.34-2.53],0.884942575956388,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,KLK4,Kallikrein-4,Inverse variance weighted,5,1.09 [0.32-3.78],0.888269363348249,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.97 [0.61-1.54],0.897960652866289,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,IL15,Interleukin-15,Inverse variance weighted,35,1.02 [0.76-1.37],0.898417902220491,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,COLEC12,Collectin-12,Inverse variance weighted,3,0.88 [0.12-6.55],0.899493227268062,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,1.04 [0.5-2.19],0.910108454733848,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.04 [0.5-2.16],0.911530314748142,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RETN,Resistin,Inverse variance weighted,19,1.02 [0.67-1.56],0.919347809955497,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,PENK,Proenkephalin-A,Inverse variance weighted,15,0.98 [0.67-1.45],0.924850020110932,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,DPY30,Protein dpy-30 homolog,Wald ratio,1,1.09 [0.14-8.38],0.931572365887658,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.04 [0.37-2.96],0.937038073985887,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.98 [0.5-1.92],0.953769592893111,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LGALS9,Galectin-9,Inverse variance weighted,36,1.01 [0.81-1.25],0.95669422778787,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.02 [0.44-2.37],0.963982600470576,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.02 [0.4-2.6],0.970642036264136,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.97 [0.24-3.93],0.970920242236381,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CSTB,Cystatin-B,Inverse variance weighted,23,1 [0.82-1.22],0.971656002083409,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.02 [0.27-3.94],0.97321398131494,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.01 [0.68-1.48],0.974082621368214,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,7,1.01 [0.5-2.02],0.979376648754666,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,0.98 [0.23-4.24],0.979750629095032,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.98 [0.08-11.59],0.986628936539926,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,SPON2,Spondin-2,Inverse variance weighted,3,1.01 [0.27-3.82],0.991268780593182,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1 [0.6-1.67],0.992882188002769,trans
Chapter IX Diseases of the circulatory system,I9_ARTEMBTHRNAS,LMOD1,Leiomodin-1,Inverse variance weighted,6,1 [0.64-1.57],0.997078751056396,trans
